Key Takeaways
- Strong quarter, inflation clouds ahead: Standalone volume grew 8% and EBITDA 18%, but crude at $100–$110 will compress margins for the next 1–2 quarters before pricing catches up.
- Home care is the engine, personal care is the drag: Home care grew 12% with broad-based momentum; personal care grew just 3%, weighed down by a muted soaps category still lapping grammage cuts.
- Indonesia has bottomed: Pricing pressures that persisted for several quarters have largely stabilized, with 4% volume growth and a clear path to mid-single-digit volume and high single-digit value growth ahead.
- Africa is transforming into a real FMCG business: 20% top-line growth was driven by air care, and the deliberate doubling of media spend behind FMCG categories signals a long-term franchise build, even as it compressed EBITDA growth to 2%.
- What to watch next quarter: Whether the 5%–7% price hikes taken in April stick without hurting volumes, the trajectory of crude oil, and the detailed guidance and portfolio update promised at the Monday investor meet.
India Standalone: The Growth Engine
- Volume-led performance: Underlying volume growth of 8% drove 10% sales growth, with EBITDA up 18% and margins at 24.7%. Disciplined cost management, calibrated pricing and improved operating leverage all contributed.
- Home care dominance: 12% value growth with consistent market share gains across household insecticide, air fresheners and fabric care. All three sub-categories delivered on both top line and bottom line.
- Air freshener breakout: Explosive growth globally on air fresheners, made in India and exported, has been the delta contributor to home care momentum.
- Personal care weakness: 3% growth reflects a muted soaps category, a declining condom/sexual wellness business, and an okay-but-not-great hair colour quarter partly affected by marriage seasonality.
- Soaps volume still lapping grammage: Small-pack grammage remains 15%–20% lower than Q4 FY25 levels despite partial restoration. Godrej #1 ₹10 pack went from 55g to 40g, then back to 46–47g. Large packs are performing better than small packs.
- Fab portfolio breaks even: The fabric care business, which has grown from nothing to ₹500 crores, achieved breakeven in Q4. Management sees a hypergrowth market with "the sky is the limit."
Sitapati: "We just think that the sky is the limit. This is a ₹4,000 crores market in India very rapidly. we've come from nowhere to becoming ₹500 crores."
International: Stabilization and Transformation
| Market | Trend | Commentary |
|---|---|---|
| Indonesia | ▬ Stabilizing | 4% volume growth, 3% sales growth. Pricing pressures have largely bottomed out; expect mid-single-digit volume and high single-digit value growth going forward. Revenue growth will now lead volume growth. |
| Africa, USA & Middle East | ▲ Strong top line | 20% sales growth driven by FMCG categories, especially air care. EBITDA grew only 2% as media spend was deliberately doubled to build a long-term franchise. Africa now looks more like a conventional FMCG business. |
| Latin America & others | ▲ Strong top line | 26% sales growth. EBITDA was impacted by one-time costs expected to normalize over coming quarters. |
- Africa base effect caveat: FY25 had a very depleted performance in Africa, so FY26 numbers come on a depleted base. Underlying FMCG drivers are expected to continue compounding in FY27.
- Indonesia margin optics: Reported margin delivery partly reflects revenue recognition reclassifications done before the Expert Advisory Committee recommendation. Underlying Indonesian margins are steady, not 28%, with a Q4 spike from Ramadan/Lebaran.
Sitapati: "the pricing pressures we have been calling out over the last several quarters have now largely bottomed out, and we are seeing increasingly clear signs of stabilization."
The Inflation Playbook: Crude vs Palm
- The crude shock: Brent moved from ~$70 to ~$100, a 40%–50% increase, while palm oil moved only 10%–11% (4,000 MYR to ~4,500 MYR). Middle distillate costs more than doubled, affecting linear alkyl benzene and kerosene used in detergents and household insecticides.
- Why this time is different: Unlike the palm oil crisis, which hit only one category and made price recovery hard, crude oil affects all categories. The same 6%–7% inflation is spread across the portfolio, making it easier to take price and recover faster.
- Price hikes already taken: Soaps: 5%. Detergents: 6%–7%. Household insecticide: 4%–5%. All implemented in April, so not reflected in Q4 results.
- Margin pressure expected: If oil stays at $100–$110, expect lower percentage margins for Q1 and probably Q2, though absolute EBITDA should remain reasonably good. Management expects to recover much sooner than in the palm oil episode.
- Volume impact manageable: Management does not expect volumes to dry up. In hyperinflationary crude environments, there are market share gains versus locals in some categories. Volumes may be a little lower than wanted, revenue growth a little higher, EBITDA slightly lower but still pretty good.
- Soaps pricing vs GST: The price increase taken will likely be less than the GST benefit passed on to consumers, so consumers will still see slightly lower soap prices compared to pre-October/pre-GST levels.
- West Asia tailwind: Rising middle distillate prices put pressure on local competitors, which from GCPL's perspective is a positive.
Sitapati: "unlike in the case of very sharp palm oil prices were even if I have a 6%-7% inflation because of palm oil, it affects only one category and then that becomes really hard to take our price. So, in the case of crude oil, it affects all categories. So, the same 6%-7% is spread out over every category."
Household Insecticide: The RNF Turnaround
- A decade-old problem resolved: Management believes the household insecticide problem that plagued the business for 10 years is probably behind them, driven by the RNF molecule.
- Growth trajectory: The category can move from zero/low single-digit growth to at least high single-digit, compounding into double-digit over time. Performance remains volatile due to seasonality.
- Weather watch: Last year was a cooler summer. If El Nino predictions hold, Q1 will be a difficult quarter for HI because a good quarter requires hot and reasonably wet conditions, which benefit Q2 and Q3. In the last El Nino year (FY24), it turned out to be a reasonably good year overall.
- RNF effectiveness: The molecule has worked better in some places than others, but overall has worked.
Sitapati: "We do feel that the household insecticide problem that plagued us for 10 years is probably behind us."
Portfolio Bets: Pet Food and the Cleansing Pivot
- Pet food: product-market fit conviction: Management is increasingly convinced they have product-market fit. A state-of-the-art plant has been set up in Nasik and volumes have been shipped. The category is a "long burn" with a lot of value to feel, and may have been entered at the right time.
- Cleansing over soaps: Management wants to change the lens from soaps to cleansing. Green shoots are visible in Cinthol body wash, Magic handwash, and the Muuchstac acquisition in face wash.
- Personal care growth ambition: The personal care business can go to 7–8% growth, though home care will structurally grow faster in the long term due to the weightage of soaps.
- Muuchstac and Raymond: Management deferred detailed discussion on these portfolio moves to the Monday investor meet.
Sitapati: "I think we are in the quest of product market fit and getting increasingly convinced we have it."
Accounting Change and Margin Optics
- Revenue presentation change: From Q4 FY26, customer-related expenditures (in-store visibility, display arrangements, mailers) are netted off from revenue rather than shown as operating expense, following an ICAI Expert Advisory Committee opinion from February 2026. Revenue and corresponding other expenses both reduce by the same amount, with no impact on absolute EBITDA, PAT, liquidity or cash flow. Margin percentages will be optically higher. Restated revenue for the last 8 quarters and 5 years has been provided.
- Indonesia reclassification: Part of Indonesia's margin delivery reflects revenue recognition reclassifications done before the EAC recommendation. Underlying margins are steady and competitive, not 28%.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Indonesia growth | Mid-single-digit volume, high single-digit value growth | FY27 onwards |
| Africa performance | Underlying FMCG drivers to continue compounding; expect quite strong performance | FY27 |
| Latin America costs | One-time costs impacting EBITDA to normalize | Coming quarters |
| EBITDA margin pressure | Lower than normative margins expected; may not be very different from last year | Q1 and probably Q2 FY27 |
| Price hike recovery | 5%–7% hikes taken in April across soaps, detergents, HI; crude-driven margin dip to recover sooner than palm oil episode | 3–4 months if oil stays at $100–$110 |
| Household insecticide growth | From zero/low single-digit to at least high single-digit, compounding into double-digit over time | Medium term |
| Tax rate | ETR likely to remain the same as FY26 | FY27 |
| Detailed guidance | Will be provided at investor meet | Monday, 11th May |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Consolidated revenue growth | 11% in INR terms, on 6% underlying volume growth |
| Consolidated EBITDA growth | 10% |
| Consolidated operating margin | 21.7% |
| Consolidated net profit after tax growth | 10% on a reported basis |
| Standalone sales growth | 10%, on 8% underlying volume growth |
| Standalone EBITDA growth | 18% |
| Standalone operating margin | 24.7% |
| Home Care value growth (India) | 12% |
| Personal Care growth (India) | 3% |
| Indonesia sales growth | 3%, on 4% underlying volume growth |
| Africa, USA and Middle East revenue growth | 20% |
| Africa, USA and Middle East EBITDA growth | 2%, reflecting deliberate doubling of media spend |
| Latin America and others sales growth | 26% |
| Blended input-cost inflation (spot) | 7% to 9%, assuming USD 100–105 Brent and 4,500 MYR CPO |
| Soaps price increase taken | 5%, effective April |
| Detergents price increase taken | 6% to 7%, effective April |
| Household insecticide price increase taken | 4% to 5%, effective April |
| Fab portfolio annualised revenue (GSV) | ~₹500 cr in Q4, ~₹450 cr in NSV terms |